Crystal structure of CHO reductase, a member of the aldo-keto reductase superfamily

Proteins: Structure, Function and Genetics

Volumn 38, Issue 1, 2000, Pages 41-48

  Ye, Qilu ^a   Hyndman, David ^a   Li, Xuhong ^a   Flynn, T Geoffrey ^a   Jia, Zongchao ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Monomeric oxidoreductase; NADPH binding site; Structure function relationship; Substrate binding site

Indexed keywords

ALDEHYDE; ALDEHYDE REDUCTASE; CYSTEINE; FIBROBLAST GROWTH FACTOR; LEUCINE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDOREDUCTASE; PROTEINASE INHIBITOR; TRYPTOPHAN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME STRUCTURE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION;

ALCOHOL OXIDOREDUCTASES; AMINO ACID SEQUENCE; ANIMALS; BENZOTHIAZOLES; CATALYTIC DOMAIN; CHO CELLS; CRICETINAE; CRYSTALLOGRAPHY, X-RAY; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NADP; PHTHALAZINES; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; THIAZOLES;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0033980901     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(20000101)38:1<41::AID-PROT5>3.0.CO;2-M     Document Type: Article

References (29)

1. Jez JM, Flynn TG, Penning TM. A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol 1997;54:639-647.
2. Kinoshita JH, Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 1988;4:323-337.
3. Hyndman DJ, Takenoshita R, Vera NL, Pang SC, Flynn TG. Cloning, sequencing, and enzymatic activity of an inducible aldo-keto reductase from Chinese hamster ovary cells. J Biol Chem 1997;272:13286-13291.
4. Otwinowski Z, Minor W. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol 1997;276:307-326.
5. Collaborative computing project No.4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D 1994;50:760-763.
6. Kissinger CR, Gehlhaar DK. EPMR: a program for crystallographic molecular replacement by evolutionary search. Version 1997.
7. Wilson DK, Nakano T, Petrash JM, Quiocho FA. 1.7 A structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor. Biochemistry 1995;34:14323-14330.
8. Brunger AT, Adams PD, Clore GM, et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D 1999;54:905-921.
9. Wilson DK, Bohren KM, Gabbay KH, Quiocho FA. An unlikely sugar substrate site in the 1.65 Å structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science 1992;257:81-84.
10. Bohren KM, Grimshaw CE, Lai CJ, et al. Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme. Biochemistry 1994;33:2021-2032.
11. El-Kabbani O, Green NC, Lin G, et al. Structures of human and porcine aldehyde reductase: an enzyme implicated in diabetic complications. Acta Crystallogr D 1994;50:859-868.
12. Hoog SS, Pawlowski JE, Alzari PM, Penning TM, Lewis M. Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/ dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. Proc Natl Acad Sci USA 1994;91:2517-2521.
13. Rondeau JM, Tete-Favier F, Podjarny A, et al. Novel NADPH-binding domain revealed by the crystal structure of aldose reductase. Nature 1992;355:469-472.
14. Borhani DW, Harter TM, Petrash JM. The crystal structure of the aldose reductase.NADPH binary complex. J Biol Chem 1992;267: 24841-24847.
15. Bennett MJ, Albert RH, Jez JM, Ma H, Penning TM, Lewis M. Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxy-steroid/dihydrodiol dehydrogenase. Structure 1997;5:799-812.
16. Wilson DK, Tarle I, Petrash JM, Quiocho FA. Refined 1.8 Å structure of human aldose reductase complexed with the potent inhibitor zopolrestat. Proc Natl Acad Sci USA 1993;90:9847-9851.
17. Cromlish JA, Flynn TG. Identification of pig brain aldehyde reductases with the high-Km aldehyde reductase, the low-Km aldehyde reductase and aldose reductase, carbonyl reductase, and succinic semialdehyde reductase. J Neurochem 1985;44:1485-1493.
18. Urzhumtsev A, Tete-Favier F, Mitschler A, et al. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure 1997;5:601-612.
19. Harrison DH, Bohren KM, Ringe D, Petsko GA, Gabbay KH. An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate. Biochemistry 1994;33:2011-2020.
20. Vander Jagt DL, Robinson B, Taylor KK, Hunsaker LA. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem 1992;267:4364-4369.
21. Petrash JM, Harter TM, Devine CS, et al. Involvement of cysteine residues in catalysis and inhibition of human aldose reductase. Site-directed mutagenesis of Cys-80, -298, and -303. J Biol Chem 1992;267:24833-24840.
22. Carper DA, Hohman TC, Old SE. Residues affecting the catalysis and inhibition of rat lens aldose reductase. Biochim Biophys Acta 1995;1246:67-73.
23. Cappiello M, Voltarelli M, Cecconi I, et al. Specifically targeted modification of human aldose reductase by physiological disulfides. J Biol Chem 1996;271:33539-33544.
24. Chandra A, Srivastava S, Petrash JM, Bhatnagar A, Srivastava SK. Active site modification of aldose reductase by nitric oxide donors. Biochim Biophys Acta 1997;1341:217-222.
25. Srivastava S, Harter TM, Chandra A, Bhatnagar A, Srivastava SK, Petrash JM. Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase. Biochemistry 1998;37:12909-12917.
26. Guengerich FP. Cytochrome P450 enzymes. In: Guengerich FP, editor. Comprehensive toxicology. Cambridge: Elsevier; 1997. p 37-68.
27. Kraulis PJ. MOLSCRIPT: a program to produce detailed and schematic plots of protein structures. J Appl Crystallogr 1991;24: 946-950.
28. Merritt EA, Bacon DJ. Raster3D: photorealistic molecular graphics. Methods Enzymol 1997;277:505-524.
29. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 1994;22:4673-4680.